Bioporto A/S logo

BIOPOR - Bioporto A/S News Story

DKK3.97 0.0  0.0%

Last Trade - 12/05/21

Sector
Industrials
Size
Small Cap
Market Cap £123.0m
Enterprise Value £114.2m
Revenue £2.85m
Position in Universe 846th / 1832

BRIEF-Bioporto FY EBIT Loss Widens To DKK 41.8 Million

Fri 22nd February, 2019 7:39am
Feb 22 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * REG-BIOPORTO ANNOUNCES ANNUAL REPORT 2018
    * 2018 REVENUE GROWTH OF 80% FROM SALES OF NGAL TEST™ IN
U.S. AND
18% IN REST OF WORLD IN 2018
    * TOTAL REVENUE OF DKK 26 MILLION IN 2018 AND AN OPERATING
LOSS OF
DKK 42 MILLION
    * REVENUE IN 2019 EXPECTED AT APPROXIMATELY DKK 40 MILLION
WITH AN
EXPECTED OPERATING LOSS OF DKK 45 MILLION
    * FY REVENUE DKK 26.0 MILLION VERSUS DKK 25.2 MILLION YEAR
AGO
    * FY EBIT LOSS DKK 41.8 MILLION VERSUS LOSS DKK 36.5 
MILLION YEAR
AGO
    * FOCUS IN 2019 WILL BE ON STRATEGIC EXECUTION AND
INCREASING
REVENUE BY 50% TO APPROXIMATELY DKK 40 MILLION
    * SAYS DRIVING FORCE WILL BE GROWING SALES OF NGAL TEST™.

Source text for Eikon:  ID:nGNE1SSDRL 
Further company coverage:  BIOPOR.CO 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.